Literature DB >> 11048799

Mutational analysis of the CTNNB1 and APC genes in uterine endometrioid carcinoma.

P W Schlosshauer1, E C Pirog, R L Levine, L H Ellenson.   

Abstract

Despite recent studies, the molecular genetic events responsible for the development of uterine endometrioid carcinoma (UEC) remain incompletely characterized. Mutations in the beta-catenin (CTNNB1) gene have been recently reported in a small percentage of UECs and in the endometrioid variant of ovarian carcinoma suggesting that the Wnt signal transduction pathway is involved in the development of female genital tract tumors with endometrioid morphology. The Wnt pathway is a critical pathway in the development of colorectal cancer (CRC) with mutations occurring in the beta-catenin (CTNNB1) or adenomatous polyposis coli (APC) genes in 10 to 15% and 85% of cases, respectively. Because UEC and CRC share other molecular genetic alterations and histologic features and previous studies of UEC have not reported an analysis of the APC gene, we chose to further elucidate the role of the Wnt pathway in UEC. To this end, we analyzed 32 cases of UEC for mutations of the CTNNB1 and APC genes. Mutations of CTNNB1 were present in six of 32 (18%) cases: four grade 1 carcinomas, one grade 2, and one grade 3 carcinoma. Five missense mutations were identified, three involving Ser/Thr phosphorylation sites and two adjacent to a Ser phosphorylation site. One case contained a deletion encompassing codons 34 to 37, which includes a Ser phosphorylation site. No mutations resulting in truncation of the APC protein were found. Our results support a role for the Wnt signaling pathway via mutation of CTNNB1, but not APC, in the development of a subset of UECs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11048799     DOI: 10.1038/modpathol.3880196

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  25 in total

1.  Expression of the Wnt antagonist Dickkopf-3 is associated with prognostic clinicopathologic characteristics and impairs proliferation and invasion in endometrial cancer.

Authors:  Thanh H Dellinger; Kestutis Planutis; Danielle D Jandial; Ramez N Eskander; Micaela E Martinez; Xiaolin Zi; Bradley J Monk; Randall F Holcombe
Journal:  Gynecol Oncol       Date:  2012-04-30       Impact factor: 5.482

2.  Genetic changes of Wnt pathway genes are common events in metaplastic carcinomas of the breast.

Authors:  Michael J Hayes; Dafydd Thomas; Agnieszka Emmons; Thomas J Giordano; Celina G Kleer
Journal:  Clin Cancer Res       Date:  2008-07-01       Impact factor: 12.531

3.  Cytoplasmic and/or nuclear accumulation of the beta-catenin protein is a frequent event in human osteosarcoma.

Authors:  Rex C Haydon; Andrea Deyrup; Akira Ishikawa; Robert Heck; Wei Jiang; Lan Zhou; Tao Feng; David King; Hongwei Cheng; Benjamin Breyer; Terrance Peabody; Michael A Simon; Anthony G Montag; Tong-Chuan He
Journal:  Int J Cancer       Date:  2002-12-01       Impact factor: 7.396

4.  Expression Patterns of the Wnt Pathway Inhibitors Dickkopf3 and Secreted Frizzled-Related Proteins 1 and 4 in Endometrial Endometrioid Adenocarcinoma: An NRG Oncology/Gynecologic Oncology Group Study.

Authors:  Ramez N Eskander; Shamshad Ali; Thanh Dellinger; Heather A Lankes; Leslie M Randall; Nilsa C Ramirez; Bradley J Monk; Joan L Walker; Eric Eisenhauer; Bang H Hoang
Journal:  Int J Gynecol Cancer       Date:  2016-01       Impact factor: 3.437

Review 5.  Molecular pathogenesis of endometrial and ovarian cancer.

Authors:  Melissa A Merritt; Daniel W Cramer
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

6.  APC and beta-catenin protein expression patterns in HNPCC-related endometrial and colorectal cancers.

Authors:  Reetta Kariola; Wael M Abdel-Rahman; Miina Ollikainen; Ralf Butzow; Päivi Peltomäki; Minna Nyström
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

Review 7.  DNA methylation in endometrial cancer.

Authors:  Meng Hua Tao; Jo L Freudenheim
Journal:  Epigenetics       Date:  2010-08-16       Impact factor: 4.528

Review 8.  Personalized therapy in endometrial cancer: challenges and opportunities.

Authors:  Shannon N Westin; Russell R Broaddus
Journal:  Cancer Biol Ther       Date:  2012-01-01       Impact factor: 4.742

9.  Beta-catenin simultaneously induces activation of the p53-p21WAF1 pathway and overexpression of cyclin D1 during squamous differentiation of endometrial carcinoma cells.

Authors:  Makoto Saegusa; Miki Hashimura; Takeshi Kuwata; Mieko Hamano; Isao Okayasu
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

10.  Differential roles of telomere attrition in type I and II endometrial carcinogenesis.

Authors:  Esra A Akbay; Cristina M Contreras; Samanthi A Perera; James P Sullivan; Russell R Broaddus; John O Schorge; Raheela Ashfaq; Hossein Saboorian; Kwok-Kin Wong; Diego H Castrillon
Journal:  Am J Pathol       Date:  2008-07-03       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.